Biotia Launches Antimicrobial Resistance Test for Complicated UTIs
The technology provides rapid resistance profiling for recurrent or complicated infections and is approved for use in all 50 US states.
The technology provides rapid resistance profiling for recurrent or complicated infections and is approved for use in all 50 US states.
PathogenDx’s UTI test is built on its D3 Array Platform. The multiplex test has a quick turnaround time with less waste.
Beckman Coulter launched its DxU Iris Workcell today at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo in Atlanta.